6 Einträge gefunden

1. Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS).

   1. Kröger, Nicolaus
   2. Shimoni, A
   3. Zabelina, Tatjana
   4. Schieder, H
   5. Panse, Jens
   6. Ayuketang Ayuk, Francis
   7. Wolschke, Christine

   2006 - Forschungsinformationssystem des UKE
2. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up.

   1. Oyekunle, A A
   2. Kröger, Nicolaus
   3. Zabelina, Tatjana
   4. Ayuketang Ayuk, Francis
   5. Schieder, H
   6. Renges, H
   7. Fehse, N

   2006 - Forschungsinformationssystem des UKE
3. Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation.

   1. Dahlke, Joachim
   2. Kröger, Nicolaus
   3. Zabelina, Tatjana
   4. Ayuketang Ayuk, Francis
   5. Wolschke, Christine
   6. Renges, Helmut-Hans
   7. Krüger, William

   2006 - Forschungsinformationssystem des UKE
4. Bortezomib after dose-reduced allogeneic stem cell transplantation for multiple myeloma to enhance or maintain remission status.

   1. Kröger, Nicolaus
   2. Zabelina, Tatjana
   3. Ayuketang Ayuk, Francis
   4. Atanackovic, Djordje
   5. Schieder, Heike
   6. Renges, Helmut
   7. Zander, Axel R.

   2006 - Forschungsinformationssystem des UKE
5. Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation.

   1. Kröger, Nicolaus
   2. Binder, Thomas
   3. Zabelina, Tatjana
   4. Wolschke, Christine
   5. Schieder, Heike
   6. Renges, Helmut
   7. Ayuketang Ayuk, Francis

   2006 - Forschungsinformationssystem des UKE
6. Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma.

   1. Kröger, Nicolaus
   2. Zagrivnaja, Maria
   3. Schwartz, Sabine
   4. Badbaran, Anita
   5. Zabelina, Tatjana
   6. Lioznov, Michael
   7. Ayuketang Ayuk, Francis

   2006 - Forschungsinformationssystem des UKE